A thickened nuchal translucency (NT) measurement, found during a first-trimester ultrasound, signals that your baby has more fluid than expected at the back of the neck. This finding raises the statistical chance of chromosomal conditions, heart defects, and certain genetic syndromes, but it does not diagnose any of them on its own. Many babies with thickened NT turn out perfectly healthy after further testing, and the measurement is best understood as a starting point for more detailed investigation rather than a verdict.
What the Measurement Actually Captures
Between roughly 11 and 14 weeks of pregnancy, every developing fetus has a thin layer of fluid under the skin at the back of the neck. Sonographers measure the thickest part of that fluid-filled space using very specific criteria: the fetus must be in a mid-sagittal view with a neutral head position, the image must be magnified so only the head and upper chest are visible, and the calipers must be placed precisely on the outer borders of the translucent space.1PubMed Central. Simplified protocol of nuchal translucency measurement: Is it still effective? Measurements below about 3 mm are generally considered normal for a single fetus, though the exact cutoff depends on gestational age and the screening program your provider uses.
When that measurement comes back thicker than expected, the fluid itself is not harmful. Research has traced the cause to swelling of the tissue around the jugular lymphatic sacs, which are small structures that eventually connect to the venous system and help drain fluid from the head and neck. In pregnancies with increased NT, these lymphatic sacs appear distended and slow to establish their connections to the veins. That delay in the lymphatic “plumbing” is what causes the temporary fluid buildup, and it may also explain why the thickening is transient in many cases.2PubMed. Increased nuchal translucency is associated with jugular lymphatic distension Problems with blood flow through the developing heart can contribute to the same buildup, which is one reason an increased NT is linked to both chromosomal and cardiac issues.
Chromosomal Conditions and the Odds
The original reason NT screening entered clinical practice was its ability to flag pregnancies at higher risk for trisomies, particularly Down syndrome (trisomy 21), Edwards syndrome (trisomy 18), and Patau syndrome (trisomy 13). One of the landmark studies found that NT thickening or cystic hygroma appeared in less than 1 percent of fetuses scanned, but among those flagged, about a quarter had an abnormal set of chromosomes. For trisomy 21 specifically, an NT measurement of 3 mm or more identified roughly 69 percent of affected fetuses.3PubMed. Screening for Down’s syndrome by fetal nuchal translucency measurement in a high-risk population That means the screen catches a majority of cases, but not all, and it also flags pregnancies where the chromosomes turn out to be perfectly normal.
The relationship between NT thickness and chromosomal risk is a gradient, not a switch. A large 2024 study in JAMA Network Open confirmed that the risk of chromosomal anomalies climbs steeply with each millimeter. Pregnancies with NT measurements between 3.0 and 3.5 mm had roughly 20 times the risk of chromosomal problems compared to those under 2.0 mm.4JAMA Network Open. Ultrasonographic Fetal Nuchal Translucency Measurements and Cytogenetic Outcomes An NT of 3.5 mm carries a different conversation than one of 6 mm. Your provider should frame the result in the context of your specific measurement, your age, and your blood-marker results, not just as “abnormal.”
Heart Defects and Other Structural Anomalies
Even when the chromosomes are completely normal, a thickened NT carries an increased chance of congenital heart defects. In chromosomally normal fetuses, those with increased NT have a risk of heart defects roughly six to seven times higher than those with normal measurements.5PubMed. Increased nuchal translucency and congenital heart defects in a low-risk population A review in Current Cardiology Reviews put the prevalence of heart defects at about 6 percent when NT exceeds 3 mm and around 20 percent when it exceeds 5.5 mm. Fetuses with NT above the 99th percentile face at least a tenfold increase in risk for major heart defects compared to the general population.6PubMed Central. Nuchal Translucency and Congenital Heart Defects
One practical benefit of catching thickened NT early is that it leads to an earlier diagnosis of heart problems when they exist. A pooled analysis of major fetal echocardiography centers found that among chromosomally normal fetuses with NT of 3.5 mm or more, the average gestational age at diagnosis of a heart defect was about 16 weeks, compared to 22 weeks in those with normal NT.7American Journal of Obstetrics and Gynecology. Nuchal translucency and fetal cardiac defects: A pooled analysis of major fetal echocardiography centers Earlier detection means more time to plan delivery at a center with pediatric cardiac surgery if needed.
Heart defects get the most attention, but thickened NT has also been linked to skeletal abnormalities. A series from one referral center documented five cases of skeletal dysplasia initially identified alongside increased NT at the routine 11-to-14-week scan.8PubMed. First-trimester ultrasound diagnosis of skeletal dysplasia associated with increased nuchal translucency thickness Other structural issues reported in the literature include diaphragmatic hernia and abdominal wall defects, though these are individually rare.
Single-Gene Disorders
A category that sometimes surprises parents is the connection between thickened NT and single-gene conditions that standard chromosome tests won’t detect. The most common of these is Noonan syndrome, a condition that affects growth, facial features, and heart development.9American Journal of Obstetrics & Gynecology. Testing for Noonan syndrome after increased nuchal translucency Because Noonan syndrome is caused by mutations in specific genes rather than by having an extra or missing chromosome, it won’t show up on a karyotype or even on standard cell-free DNA screening. Targeted genetic testing is needed to detect it, and it’s something your genetic counselor may discuss if the NT is elevated but all other tests come back normal.
What Testing Happens After a Thickened NT
A thickened NT on its own doesn’t tell you what, if anything, is going on. It’s the first tile in a mosaic that your care team will fill in over weeks. The typical path involves some combination of blood markers, non-invasive prenatal testing (NIPT) using cell-free DNA from a blood draw, and potentially invasive diagnostic tests.
If the combined first-trimester screen (NT measurement plus blood markers) places you in a higher-risk category, your provider will usually offer diagnostic testing through chorionic villus sampling (CVS) or amniocentesis. These tests analyze actual fetal cells rather than screening probabilities, so they can confirm or rule out chromosomal conditions with high certainty. Data from a five-year tertiary center review found that among pregnancies referred for CVS due to increased NT, about 27 percent had a chromosomal abnormality detected.10PubMed Central. Consecutive 5-year outcomes of chorionic villus sampling at a tertiary center That number reflects a pre-selected group already flagged as higher risk, so it shouldn’t be read as the overall rate for everyone with thickened NT.
When standard karyotyping and chromosomal microarray come back normal but the NT was significantly elevated, more advanced genetic workup may be warranted. Chromosomal microarray analysis (CMA) picks up small deletions and duplications that karyotyping misses, with a diagnostic yield for significant findings of roughly 18 percent in one large cohort of fetuses with NT of 3 mm or more.11American Journal of Obstetrics and Gynecology. Diagnostic yield of chromosomal microarray analysis and prenatal exome sequencing in fetuses with increased nuchal translucency Among those who had negative microarray results but NT of 3.5 mm or more, whole-exome sequencing identified a causative genetic variant in about 10 percent of tested cases.11American Journal of Obstetrics and Gynecology. Diagnostic yield of chromosomal microarray analysis and prenatal exome sequencing in fetuses with increased nuchal translucency Genome sequencing, still relatively new in prenatal diagnostics, has shown even higher yields in smaller studies, roughly doubling the detection rate compared to standard CMA and karyotyping combined.12PubMed Central. Prenatal Diagnosis of Fetuses With Increased Nuchal Translucency by Genome Sequencing Analysis
The upshot is that there is a ladder of increasingly detailed genetic investigation available. Not every pregnancy with thickened NT needs to climb every rung. Your provider and genetic counselor will tailor the workup to the degree of NT elevation, what other findings exist on ultrasound, and your own preferences for how much information you want.
When the Thickening Resolves on Its Own
One piece of information that genuinely changes the picture is whether the NT thickening persists or disappears on follow-up scans. A 2025 systematic review and meta-analysis addressed this directly, examining what happens when early increased NT is followed up at the standard 11-to-14-week window. When the fluid remained elevated at that scan, adverse outcomes occurred in about 64 percent of cases. But when the thickening resolved before or by the time of the standard scan, adverse outcomes dropped to roughly 19 percent.13PubMed. Outcome of fetuses with early increased nuchal translucency: systematic review and meta-analysis
Resolution doesn’t guarantee everything is fine, but it dramatically shifts the odds in a favorable direction. If your provider notes that a previously thick NT has resolved by the repeat scan, the overall risk profile looks meaningfully better, though follow-up imaging in the second trimester is still recommended.
Long-Term Outcomes When Everything Else Looks Normal
For parents going through the weeks of anxiety between a thickened NT result and the eventual “all clear” on further testing, the question that matters most is what happens to the baby long-term. The research here is genuinely reassuring, with some important caveats.
A prospective study followed children who had NT at or above the 99th percentile but normal chromosomes and normal detailed ultrasound findings at 22 to 24 weeks. The study concluded that when the mid-pregnancy anatomy scan shows no problems, the risk of adverse neonatal outcomes or developmental delay in early childhood is not increased compared to the general population.14PubMed Central. Long-term outcome of children born after a first-trimester measurement of nuchal translucency at the 99th percentile or greater with normal karyotype: a prospective study A separate retrospective cohort reached essentially the same conclusion: if the karyotype is normal and detailed ultrasound scans during pregnancy plus a thorough pediatric evaluation at birth are normal, the risk of adverse outcomes at school age matches the general population.15PubMed. Pregnancy outcome and long-term follow-up of fetuses with isolated increased NT: a retrospective cohort study
A longer-term Finnish cohort study of 733 children followed for an average of six and a half years offered a more nuanced picture. Among chromosomally normal children who had increased NT but a normal second-trimester anatomy scan, about 7 percent were eventually found to have a major health problem when adding up previously published cases with newly identified ones over the follow-up period.16PubMed. Long-term outcome in apparently healthy children with increased nuchal translucency in the first trimester screening That 7 percent figure includes structural defects, genetic disorders, and neurodevelopmental issues detected over years of follow-up. It’s higher than the baseline rate in the general population and is worth knowing about, but it also means that the vast majority of these children were healthy at follow-up. The key conditioning factor across all these studies is the detailed anatomy scan around 20 to 22 weeks: if that scan is clean, the long-term outlook is substantially better.
The Emotional Weight of the Result
Something the clinical data can’t fully capture is how destabilizing an abnormal NT result feels in real time. You’re told about a statistical risk at a point in pregnancy when you can’t yet feel the baby move and when answers are weeks away. One study examining outcomes after first-trimester screening found that about 11 percent of parents in their cohort chose to terminate the pregnancy due to anxiety and uncertainty about the future, and some of those pregnancies later turned out to have normal chromosomes.17PubMed Central. Increased Nuchal Translucency and Pregnancy Outcome The authors attributed part of this to overly cautious counseling that amplified fear rather than framing the finding in proportion.
Genetic counseling from someone experienced with NT results can make a real difference here. The goal of that conversation should be to walk you through the specific numbers for your measurement, your age, and your blood results, not to present a list of everything that could go wrong. Asking your provider to refer you to a maternal-fetal medicine specialist or a genetic counselor rather than relying on a brief explanation during a routine appointment is reasonable and worth advocating for.
NT Screening in Twin Pregnancies
If you’re carrying twins, NT screening serves a somewhat different role depending on whether your twins share a placenta. In dichorionic twins (separate placentas), increased NT functions similarly to singleton pregnancies in flagging chromosomal risk, though the interpretation is done per twin. In monochorionic twins (shared placenta), the measurement takes on an additional dimension: it can be an early warning sign of twin-to-twin transfusion syndrome (TTTS), a serious complication where blood flow between the twins becomes unbalanced.
A study of twin pregnancies found that monochorionic twins with increased NT in one or both fetuses had significantly higher rates of twin-specific complications compared to those with normal measurements.18PubMed Central. Clinical Utility of Increased Nuchal Translucency at 11–13 Weeks of Gestation in Twin Pregnancies Based on the Chorionicity Specifically, when the difference in NT between the two twins is large, the risk of severe TTTS climbs. Research suggests that when the discordance in NT between monochorionic twins is 20 percent or more, the detection rate for severe TTTS is about 52 percent, though this comes at the cost of a 20 percent false-positive rate.19PubMed. Discordance in nuchal translucency thickness in the prediction of severe twin-to-twin transfusion syndrome
Early work also suggested that combining discordant NT with abnormal blood flow through the ductus venosus in the twin with the thicker measurement could sharpen prediction. In cases where both markers were abnormal, TTTS eventually developed, while in twins with discordant NT but normal ductus venosus flow, the syndrome did not develop.20Twin Research. Anticipating twin–twin transfusion syndrome in monochorionic twin pregnancy. Is there a role for nuchal translucency and ductus venosus blood flow evaluation at 11–14 weeks? The sample sizes in these early studies were small, so the predictive value is imperfect, but the principle has held up: for monochorionic twins, NT screening pulls double duty, flagging both chromosomal risk and hemodynamic instability between the pair. If you’re carrying monochorionic twins and the NT measurements are notably different between the two, expect your care team to schedule more frequent monitoring for TTTS in the second trimester.